Emerging Questions in the Face of Multiple Effective Therapies

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker's Bureau - AstraZenca; Intellia
• Grant - Pfizer
• Grant/Research - Alnylam; Eidos
• Grant Support/Research Contract - Ionis; Attralus